Latest News

  • PARTNERSHIPS

    16 Dec 2025

    Why Moderna’s Nanexa Pact Matters More Than It Looks
  • INNOVATION

    12 Dec 2025

    How Advanced Manufacturing Is Reshaping US Pharma
  • PARTNERSHIPS

    9 Dec 2025

    Halozyme Bets Big on the Future of Biologics Delivery
  • RESEARCH

    21 Nov 2025

    Why Drug Delivery Is the New Power Move

Can One Small Shot Last a Year? MIT Thinks So

MIT campus sign in front of the university’s main entrance with people walking past

INNOVATION

19 Nov 2025

A preclinical MIT injection draws growing attention from drugmakers

Vaccine vials and syringe displayed in front of the Moderna logo.

PARTNERSHIPS

16 Dec 2025

Why Moderna’s Nanexa Pact Matters More Than It Looks

Moderna’s pact with Nanexa spotlights drug delivery as biotech’s next growth engine, accelerating long-acting injectables and reshaping co...

Automated pharma filling line preparing vials in advanced manufacturing facility

INNOVATION

12 Dec 2025

How Advanced Manufacturing Is Reshaping US Pharma

US drugmakers expand advanced manufacturing as supply risks and new FDA frameworks push modernization

Syringes and biologic drug delivery components displayed on a clean lab surface

PARTNERSHIPS

9 Dec 2025

Halozyme Bets Big on the Future of Biologics Delivery

Halozyme’s Elektrofi buy boosts ultra concentrated biologics delivery and widens partnering prospects as demand for simpler dosing acceler...

Scientist in cleanroom gear working with sterile bioprocessing equipment.

RESEARCH

21 Nov 2025

Why Drug Delivery Is the New Power Move

Halozyme, BrYet, and Merus push drug delivery from niche science to a central force in modern medicine

MIT campus sign in front of the university’s main entrance with people walking past

INNOVATION

19 Nov 2025

Can One Small Shot Last a Year? MIT Thinks So

A preclinical MIT injection draws growing attention from drugmakers

Exterior view of Halozyme building featuring logo above main entrance.

INNOVATION

14 Nov 2025

Can Tiny Injections Replace Big Infusions

Halozyme’s move to buy Elektrofi puts high dose injectables at the center of a push for simpler biologic care

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.